Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Hematology > Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes > Flashcards

Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes Flashcards

1
Q

Course of aplastic anemia after immunosuppressive Rx

A

15% may develop MDS heralded by reappearance of pancytopenia

leukemia

hemolysis due to PNH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Phenotype of fanconi anemia patients

A

short stature

cafe au lait spots

thumb and radii abnormalities

genitourinary tract abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Time for granulocyte count improvement in aplastic anemia after immunosuppressive Rx

A

2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anticonvulsants associated with aplastic anemia

A

hydantoins

carbamazepine

phenacemide

felbamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In aplastic anemia evidence of replacement of marrow by fat is seen in

A

BMA

MRI spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PS in aplastic anemia

A

large erythrocytes

paucity of platelets and granulocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common infectious cause of bone marrow failure

A

Hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood picture in myelofibrosis

A

anemia is dominant

normochromic,normocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Systemic diseases causing pancytopenia with cellular marrow

A

Systemic lupus erythematosus

Hypersplenism

B12, folate deficiency

Overwhelming infection

Alcohol

Brucellosis

Sarcoidosis

Tuberculosis

Leishmaniasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cytogenetics with good prognosis in MDS

A

del 5q

del 20q

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Late effects of radiation

A

MDS

Leukemia

Not aplastic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presentation of eosinophilic fascitis

A

painful induration of subcutaneous tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hematopoietic cells occupy less than _____ % of marrow space in aplastic anemia

A

25

severe cases fat is 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mean age of onset of MDS

A

70 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Infection as initial manifestation of aplastic anemia

A

Unusual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cytogenetic abnormalities associated with MDS

A

del 5,7,20

trisomy 8(responds to immunosuppressive therapy)

11q23(topoisomerase inhibitors)

t(5;12)CMML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Infectious cause of marrow fibrosis

A

Mycobacteria

fungi

HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PS: Nucleated RBCs with pancytopenia

A

Marrow fibrosis

tumor invasion of marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Shwachman-Diamond syndrome

A

Marrow failure

pancreatic insufficiency leading to malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bone marrow in MDS

A

hypercellular or normal

20%-hypocellular

ringed sideroblasts in erythroid lineage

megaloblastic nuclei with defective hemoglobinisation

increase in myeloblasts

granulocytic precursor and megakaryocyte abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Monoclonal antibody is useful in MDS pts with which characteristics

A

young(

favourable IPSS

HLA-DR15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MCV in aplastic anemia

A

Increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Skin and joint symptoms of parvo virus infection are due to

A

immune complex deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which is more common in MDS? aneuploidy or translocations

A

Aneuploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MDS blood studies

A

Anemia alone or as a part of bi/pancytopenia

isolated thrombocytopenia/granulocytopenia is rare

macrocytes

dimorphic anemia

Platelets are large and lack granules

Total WBC count is normal or low

Neutrophils are hypogranulated,ringed or hyposegmented nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

poor prognostic factors in MDS

A

Therapy related MDS

worsening of pancytopenia

acquisition of new chromosomal abnormalities (chromosome 7 abnormalities)

increase in the number of blasts

marrow fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

peripheral smear in myelofibrosis

A

leukoerythroblastosis

nucleated RBC,tear drop

leukemoid reaction like picture

abundant,giant platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Phenotype of dyskeratosis congenita

A

mucous membrane leukoplakia

dystrophic nails

reticular hyperpigmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Family history suggestive of constitutive etiology of aplastic anemia

A

hematologic disorders

pulmonary or hepatic fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

myelophthisis

A

secondary myelofibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Immune diseases causing aplastic anemia

A

Eosinophilic fasciitis
Hyperimmunoglobulinemia
Thymoma/thymic carcinoma
Graft-versus-host disease in immunodeficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Mutation in PNH

A

PIG-A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Treatment of persistent B19 infection

A

Intravenous immunoglobulin therapy (e.g., 0.4 g/kg daily for 5 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Connective tissue disorders with PRCA

A

SLE

RA

JRA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Cytopathic sign of parvovirus B19 infection

A

Giant pronormoblast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Bone marrow failure states

A

aplastic anemia, myelodysplastic syndrome (MDS), pure red cell aplasia (PRCA), and myelophthisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Etiology of most cases of aplastic anemia

A

idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

congenital thrombocytopenia

A

Amegakaryocytic thrombocytopenia

Thrombocytopenia with absent radii

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Presentation of hepatits induced pancytopenia

A

young men

hepatits due to non-A, non-B, non-C cause 1-2 months earlier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Dry tap with pancytopenia

A

Myelofibrosis

Myelophthisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Drugs causing PRCA

A

phenytoin, azathioprine, chloramphenicol, procainamide, isoniazid,erythropoietin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Diagnosis of parvovirus infection

A

Detection of viral DNA sequences in the blood (IgG and IgM antibodies are commonly absent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Management of anemia in aplastic anemia

A

2 units every 2 weeks

deferoxamine and deferasirox at fiftieth transfusion

Target Hb: 7 g/dl(9 g/dl if underlying cardiac or pulmonary disease is present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

MDS

A

cytopenia with dysmorphic and usually cellular marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Role of lenalidomide in MDS

A

Reverses anemia in MDS patients with 5q deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

pathophysiologic features of myelophthisis

A

proliferation of fibroblasts in the marrow space

myeloid metaplasia(spleen,liver,nodes,long bones)

ineffective erythropoiesis

35
Q

Cause of aplastic anemia in immunodeficient patients

A

Transfusion-associated graft-versus-host disease (GVHD)

36
Q

Congenital agranulocytosis

A

Kostmann’s syndrome

Shwachman-Diamond syndrome

37
Q

Most common isolated cytopenia

A

agranulocytosis

39
Q

Characteristics of hypoproliferative anemias

A

normochromic, normocytic, or macrocytic and are characterized by a low reticulocyte count

39
Q

PS: abnormal platelets with pancytopenia

A

MDS

peripheral destruction

40
Q

Age distribution of acquired aplastic anemia

A

biphasic

40
Q

Management of bleeding in aplastic anemia

A

Platelet transfusions to maintain count >10,000/µL(SDAP or HLA matched platelet transfusions)

Suppression of menstruation

avoid NSAID

41
Q

Rx for aplastic anemia

A

HSCT

ATG+cyclosporine

high dose cyclophosphamide

? androgens(increase telomerse activity)

42
Q

Hematologic syndromes that can cause myelofibrosis

A

CML

Hairy cell leukemia

MM

lymphoma

43
Q

Viral causes of aplastic anemia

A

Epstein-Barr virus (infectious mononucleosis)
Hepatitis (non-A, non-B, non-C hepatitis)
Parvovirus B19 (transient aplastic crisis, PRCA)
HIV-1 (AIDS)

44
Q

Empirical treatment of infections in aplastic anemia

A

broad spectrum antibiotics

ceftazidime or combination of aminoglycosides,cephalosporines,semisynthetic penicillin

46
Q

Chemical causing aplastic anemia

A

Benzene

48
Q

Inherited causes of aplastic anemia

A

Fanconi’s anemia

Dyskeratosis congenita

Shwachman-Diamond syndrome

Reticular dysgenesis

Amegakaryocytic thrombocytopenia

Familial aplastic anemias

Preleukemia (monosomy 7, etc.)

Nonhematologic syndrome (Down, Dubowitz, Seckel)

50
Q
A

Dyskeratosis congenita

50
Q

Drugs used in MDS

A

Azacitidine s.c

Decitabine i.v

51
Q

pancytopenia with granulomas in bone marrow

A

Infectious etiology

53
Q

Correlation between marrow cellularity and severity of aplastic anemia

A

imperfect

marrow cellularity decreases with aging

54
Q

X linked dyskeratosis congenita is due to mutations in

A

DKC1(dyskerin)

56
Q

Dyskeratosis is due to mutations in

A

telomere repair complex

57
Q

Progression to pancytopenia or leukemia in single lineage failure syndromes

A

unusual

58
Q

Treatment of aplastic anemia in older pts

A

Immunosuppresion is preferred

profound neutropenia: transplant

58
Q

Viral causes of PRCA

A

Persistent B19 parvovirus, hepatitis, adult T cell leukemia virus, Epstein-Barr virus

59
Q

Persistent or recrudescent fever in aplastic anemia

A

fungal infection

candida

aspergillus

60
Q

clastogenic agents

A

Mitomycin C

diepoxybutane

61
Q

Congenital PRCA

A

Diamond-Blackfan anemia

62
Q

Parvovirus tropism for erythroid precursors is due to

A

Use of erythrocyte P antigen as cellular receptor for entry

63
Q

DD for MDS

A

B12,folate,B6 deficiency

AML

Aplastic anemia

65
Q

Antibiotics associated with aplastic anemia

A

chloramphenicol

quinacrine

chloroquine

sulfonamides

66
Q

Demography of agranulocytosis

A

older adults and women

68
Q

Pancytopenia with hypocellular marrow

A

Acquired aplastic anemia

Constitutional aplastic anemia (Fanconi’s anemia, dyskeratosis congenita)

Some myelodysplasia

Rare aleukemic leukemia

Some acute lymphoid leukemia

Some lymphomas of bone marrow

70
Q

Tumors causing PRCA

A

Thymoma

Lymphoid malignancies

Paraneoplastic syndrome of solid tumors

71
Q

Skin lesions in MDS

A

Sweet syndrome

73
Q

Drugs associated with aplastic anemia

A

NSAID(esp phenylbutazone)

Heavy metals (gold, arsenic, bismuth, mercury)

antithyroid drugs (methimazole, methylthiouracil, propylthiouracil)

antidiabetes drugs (tolbutamide, chlorpropamide)

carbonic anhydrase inhibitors (acetazolamide and methazolamide)

Antihistamines (cimetidine, chlorpheniramine)

d-Penicillamine

Estrogens

75
Q

Highly atypical physical examination features in aplastic anemia

A

lymphadenopathy

splenomegaly

75
Q

Which diseases can evolve to MDS

A

acquired aplastic anemia following immunosuppressive treatment and Fanconi’s anemia

76
Q

Poor prognostic factors in aplastic anemia

A

ANC

Platelet count

corrected reticulocyte count< 1% or absolute reticulocyte count

77
Q

Daclizumab

A

antibody to the high affinity IL-2 receptor

78
Q

In utero B19 parvovirus infection

A

Nonimmune hydrops fetalis

80
Q

Rx of idiopathic PRCA

A

glucocorticoids,cyclosporine, ATG, azathioprine, cyclophosphamide, and daclizumab

81
Q

Monoclonal ab used in MDS

A

Anti CD52

Alemtuzumab

82
Q

Adverse effects of lenalidomide

A

thrombocytopenia

neutropenia

DVT/PE

83
Q

Causes of hypocellular marrow with or without cytopenias

A

Q fever

Legionnaires’ disease

Anorexia nervosa, starvation

Mycobacterium

84
Q

azacytidine

A

Pyramidine analogue

cytotoxic and demethylating agent

85
Q

time required for correction of anemia with lenalidomide therapy in MDS

A

3 months

87
Q

Systemic complaints and weight loss in aplastic anemia

A

Point to other etiologies

88
Q

side effects of azacitidine and decitabine

A

Myelosuppression

89
Q

Most common early symptom in aplastic anemia

A

bleeding

90
Q

Role of vancomycin in aplastic anemia

A

contamination of indwelling plastic catheters

91
Q

Difference between MDS and aplastic anemia

A

Morphologic abnormalities of megakaryocytes and myeloid precursor cells

typical cytogenetic abnormalities

92
Q

Causes of secondary marrow fibrosis

A

Sarcoidosis

gaucher

osteopetrosis

radiation or radiomimetic alkylating agents

93
Q

solid tumors causing marrow fibrosis

A

lung

breast

prostate

neuroblastoma

95
Q

Presentation of acquired aplastic anemia

A

abrupt onset of low blood counts in a previously well young adult

97
Q

PS: presence of immature myeloid forms with pancytopenia

A

Leukemia

MDS

99
Q

Role of Hematopoietic growth factors in aplastic anemia

A

No role

101
Q

Best Rx for young patient with aplastic anemia

A

fully histocompatible sibling donor HSCT

102
Q

Physical signs in MDS

A

Pallor

Splenomegaly(20%)

103
Q

Family h/o MDS

A

fanconi

sideroblastic anemia

104
Q

Most common type of MDS

A

Refractory anemia with excess blasts

105
Q

Immunosuppressive Rx in aplastic anemia

A

ATG and cyclosporine

106
Q

Self limited causes of PRCA

A

Transient erythroblastopenia of childhood
Transient aplastic crisis of hemolysis (acute B19 parvovirus infection)

107
Q

Side effect of ATG treatment

A

serum sickness

flu like illness

rash

arthralgia

occurs 10 days after initiating treatment

108
Q

PRCA can be major manifestation of which lymphoid tumors

A

Large granular lymphocytosis

CLL

109
Q

Side effects of cyclosporine

A

hypertension

nephrotoxicity

seizures

Pcp infection

110
Q

BMA in aplastic anemia is _________ on smear

A

dilute

111
Q

Secondary MDS

A

Radiation

Benzene

Radiomimetic alkylating agents( busulfan, nitrosourea, or procarbazine )

DNA topoisomerase inhibitors

112
Q

Children with down syndrome are susceptible to

A

MDS

AML

113
Q

Primary bone marrow diseases causing pancytopenia with cellular marrow

A

Myelodysplasia

Paroxysmal nocturnal

hemoglobinuria

Myelofibrosis

Some aleukemic leukemia

Myelophthisis

Bone marrow lymphoma

Hairy cell leukemia

Hematology (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions